News - Page 266 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Champignon Provides Corporate Update

Champignon Provides Corporate Update

Post published:July 13, 2020
Post category:Press Release

Read more about the article ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse

Post published:July 9, 2020
Post category:Press Release

Read more about the article MagicMed Industries Files First Psychedelic Derivative Patent

MagicMed Industries Files First Psychedelic Derivative Patent

Post published:July 9, 2020
Post category:Press Release

Read more about the article Pharmadrug Inc. Provides Update on Debt Restructuring

Pharmadrug Inc. Provides Update on Debt Restructuring

Post published:July 9, 2020
Post category:Press Release

Read more about the article Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

Post published:July 9, 2020
Post category:Press Release

Read more about the article Osoyoos Provides Corporate Update on AI Pharma Acquisition

Osoyoos Provides Corporate Update on AI Pharma Acquisition

Post published:July 8, 2020
Post category:Press Release

Read more about the article Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Post published:July 7, 2020
Post category:Press Release

Read more about the article Steve Sadoff, CEO, CannaGlobal Wellness

Steve Sadoff, CEO, CannaGlobal Wellness

Post published:July 7, 2020
Post category:Interview

Read more about the article Professor David Nutt Joins AWAKN Life Sciences

Professor David Nutt Joins AWAKN Life Sciences

Post published:July 7, 2020
Post category:Press Release

Read more about the article IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

Post published:July 7, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.